BioStratum, CRN Spar Over Pyridoxamine’s Pre-DSHEA Marketing Status

BioStratum insists there is no evidence supporting the Council for Responsible Nutrition's claim that pyridoxamine was sold as a dietary ingredient before 1994 and says the ingredient should not be considered "grandfathered" under DSHEA

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet